To monitor oseltamivir-resistant influenza viruses A (H1N1) (ORVs) with H275Y in neuraminidase (NA) in Japan during 2 influenza seasons, we analyzed 3,216 clinical samples by NA sequencing and/or NA inhibition assay. The total frequency of ORVs was 2.6% (45/1,734) during the 2007–08 season and 99.7% (1,477/1,482) during the 2008–09 season, indicating a marked increase in ORVs in Japan during 1 influenza season. The NA gene of ORVs in the 2007–08 season fell into 2 distinct lineages by D354G substitution, whereas that of ORVs in the 2008–09 season fell into 1 lineage. NA inhibition assay and M2 sequencing showed that almost all the ORVs were sensitive to zanamivir and amantadine. The hemagglutination inhibition test showed that ORVs were ant...
Emergence of influenza viruses with reduced susceptibility to neuraminidase inhibitors (NAIs) is spo...
Background: Continuous monitoring of influenza antiviral susceptibility has become more important si...
Background: Antiviral susceptibility surveillance in the Netherlands was intensified after the first...
To monitor oseltamivir-resistant influenza viruses A (H1N1) (ORVs) with H275Y in neuraminidase (NA) ...
To monitor and characterize oseltamivir-resistant (OR) pandemic (H1N1) 2009 virus with the H275Y mut...
Abstract Background Oseltamivir is the preferred antiviral drug for influenza, but oseltamivir-resis...
The surveillance of seasonal influenza virus susceptibility to neuraminidase (NA) inhibitors was con...
Despite greater than 99% of influenza A viruses circulating in the Asia-Pacific region being resista...
AbstractFour World Health Organization (WHO) Collaborating Centres for Reference and Research on Inf...
The surveillance of seasonal influenza virus susceptibility to neuraminidase (NA) inhibitors was con...
AbstractObjectivesTo monitor antiviral drug resistance among seasonal influenza viruses isolated in ...
Emergence of influenza viruses with reduced susceptibility to neuraminidase inhibitors (NAIs) is spo...
Pandemic influenza A(H1N1) 2009 virus was first detected in Japan in May 2009 and continued to circu...
In Europe, the 2007–08 winter season was dominated by influenza virus A (H1N1) circulation through w...
In Europe, the 2007/08 winter season was dominated by influenza virus A (H1N1) circulation through w...
Emergence of influenza viruses with reduced susceptibility to neuraminidase inhibitors (NAIs) is spo...
Background: Continuous monitoring of influenza antiviral susceptibility has become more important si...
Background: Antiviral susceptibility surveillance in the Netherlands was intensified after the first...
To monitor oseltamivir-resistant influenza viruses A (H1N1) (ORVs) with H275Y in neuraminidase (NA) ...
To monitor and characterize oseltamivir-resistant (OR) pandemic (H1N1) 2009 virus with the H275Y mut...
Abstract Background Oseltamivir is the preferred antiviral drug for influenza, but oseltamivir-resis...
The surveillance of seasonal influenza virus susceptibility to neuraminidase (NA) inhibitors was con...
Despite greater than 99% of influenza A viruses circulating in the Asia-Pacific region being resista...
AbstractFour World Health Organization (WHO) Collaborating Centres for Reference and Research on Inf...
The surveillance of seasonal influenza virus susceptibility to neuraminidase (NA) inhibitors was con...
AbstractObjectivesTo monitor antiviral drug resistance among seasonal influenza viruses isolated in ...
Emergence of influenza viruses with reduced susceptibility to neuraminidase inhibitors (NAIs) is spo...
Pandemic influenza A(H1N1) 2009 virus was first detected in Japan in May 2009 and continued to circu...
In Europe, the 2007–08 winter season was dominated by influenza virus A (H1N1) circulation through w...
In Europe, the 2007/08 winter season was dominated by influenza virus A (H1N1) circulation through w...
Emergence of influenza viruses with reduced susceptibility to neuraminidase inhibitors (NAIs) is spo...
Background: Continuous monitoring of influenza antiviral susceptibility has become more important si...
Background: Antiviral susceptibility surveillance in the Netherlands was intensified after the first...